|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.11 USD | +2.63% |
|
+1.97% | +5.21% |
| Jan. 13 | Illumina Announces Alliance Framework with AstraZeneca, Merck, and Eli Lilly and Company | CI |
| Jan. 13 | Illumina introduces Billion Cell Atlas, genome-wide genetic perturbation dataset | RE |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 269B | A | |||||||
| 964B | A | |||||||
| 515B | BBB | |||||||
| 390B | AA | |||||||
| 363B | AA | |||||||
| 292B | A | |||||||
| 272B | AAA | |||||||
| 265B | A | |||||||
| 175B | A | |||||||
| 151B | AAA | |||||||
| 143B | BBB | |||||||
| 114B | A | |||||||
| 115B | AA | |||||||
| 114B | A | |||||||
| 100B | AA | |||||||
| 87.23B | AA | |||||||
| 63.66B | - | - | - | - | - | - | - | |
| 61.48B | AA | |||||||
| 49.82B | AA | |||||||
| 48.88B | AA | - | ||||||
| Average | 227.68B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
